Authority constructs and identifiers have been used by CAS within the chemistry sector for almost 100 years as the cornerstone of our world-leading curating and indexing. Our life sciences team is now creating the same indexing tools for a new industry. In this article, we chat with Nicole Stobart, Senior Capabilities Manager in Life Sciences; Jeff Wilson, Ph.D., Assistant Director, Content Strategy and Authority; and Mark Schmidt, Lead Data Steward, about how they are forging this new path using authority constructs.
CAS: What are authority constructs, and why are they important to life sciences research?
CAS: How would you define data curation at CAS?
CAS: What would you say is the advantage of authority constructs for curation?
CAS: Can AI be leveraged to help create authority constructs or curate with them?
CAS: How is CAS going to approach defining and identifying biological entities?
CAS: Are you using structure or function to create these identities for life sciences?
CAS: How do you plan to tackle the longevity of defining by function when biological function changes over time and with new research?
CAS: What makes CAS the right organization to curate this fragmented data?
CAS: How is what you’re doing different than what’s already been done?
CAS: Have you had any pushback from the other existing databases as you move into this space?
CAS: If had a magic wand to change anything in the drug discovery process, what would you change?
